RBL001/RBL002 Phase I Clinical Trial (Q64641712)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RBL001/RBL002 Phase I Clinical Trial |
clinical trial |
Statements
MERIT (English)
0 references
Clinical First-in-human Dose Escalation Study Evaluating the Safety and Tolerability of Intranodal Administration of an RNA-based Cancer Vaccine Targeting Two Tumor-associated Antigens in Patients With Advanced Melanoma (English)
0 references
June 2012
0 references
May 2015
0 references
29
0 references
18 year
0 references